Best Clinics and Costs for Obstetrics and Gynecology in United Arab Emirates 2024

Dr. Namrata Jadhav brings with her more than 14 years of experience in the field of Obstetrics and Gynaecology. She has pursued MBBS, DNB, GO, MNAMS from leading colleges and hospitals in Mumbai, India. She has obtained training in Cosmetic Gynaecology in UAE. She has also taken laparoscopic training in a year 2016 and 2022.Dr. Namrata is proficient in High-Risk Obstetrics, hypertension/diabetes in pregnancy, recurrent abortions, previous LSCS, vaginal birth after LSCS, management of pregnancy after IV/in treatment, just to name a few.She also has a passion for pre-pregnancy, pregnancy counselling to make the journey a memorable, postpartum care and weight management, and is even known for painless pap smears and examinations. Dr. Namrata is also proficient in treating recurrent UTI/vaginal infections, handling cosmetic gynaecology cases, and is an expert when it comes to POS management, PCO related issues, and abnormal bleeding in adolescence.

Dr. Hosam is a Consultant Obstetrician, Gynecologist, and Urologist. He worked for 20 years in the NHS in the United Kingdom after obtaining his CCST as a Consultant Gynecologist with known expertise in the management of high-risk pregnancy, complex benign gynecology, and early-stage gynecological cancer. He worked as a Consultant and the Lead Urogynecologist at Sussex Healthcare Trust, where he has been practicing since 2004. Dr. Hosam has a special interest in prolapse, urinary incontinence, sexual dysfunction ( preservation surgery), menorrhagia, and minimally invasive laparoscopic and hysteroscopic gynecological surgery (for abnormal bleeding, pelvic masses, and pelvic pain). He established an integrated multidisciplinary urogynecology team across the trust. He had led the obstetrics and gynecology department as a clinical director to attain national British Society of Urogynecology accreditation. He has extensive clinical and surgical expertise to manage urinary incontinence, frequency, urgency, and recurrent cystitis and to perform pelvic reconstructive surgery for incontinence and uterovaginal prolapse. A subjective retrospective audit of his continence surgery showed a success rate of 86% and a success rate of prolapsed surgery of 91%. He is also interested in the management of sexual dysfunction, including vaginal corrective surgery. Dr. Hosam was chosen to be a Member of the International Urogynecology Association’s Publication Committee, and he was also the Editor of the expert corner in the IUGA newsletter. His areas of expertise include, Minimally invasive laparoscopic and hysteroscopic surgery Menorrhagia, fibroid, and endometriosis Laparoscopic myomectomy and hysterectomy Urogynecology, pelvic floor surgery, and recurrent prolapse Female stress incontinence surgery High-risk pregnancy Prolapse and pelvic floor surgery Pelvic reconstruction surgery Stress incontinence treatment Urodynamics Urogynecology Endometriosis Fibroids Hysteroscopy Menopause and psychosexual problems Menorrhagia Laparoscopic hysterectomy and myomectomy Stress incontinence surgery (none mesh and minimally invasive procedures) Day case stress incontinence procedure without surgery Anal sphincter incontinence surgery Abdominal and vaginal suspension procedures Menstrual disorders Miscarriage Painful periods Pelvic/perineal pain Postpartum obstetric anal sphincter injuries Research & Publications Serum Cupper and Zinc in Unexplained In Anti HLA Abs in Recurrent Miscarriage and Effect of Immune Therapy on Pregnancy Outcomes Unusual presentation of PRESS in the postnatal period. BMJ Case Reports 2014; doi:10.1136/bcr-2013-203406 Subphrenic abscess resulting in multi organ failure after Caesarean Section - case report. J. of obstet&Gynae.Vol 30; No.3,312-314,2010. Long Term outcome of the telephone follow up clinic in gynaecological setting. Int. J. of healthcare administration.vol 7, No.1.,2010. Role of 3D ultrasound in the diagnosis of rare case of angular pregnancy. The Internet Journal of Gynaecology and Obstetrics. 2009 Volume 11 Number 2. Unusual presentation of ectopic pregnancy. Therapeutic forum,MIMS Women's Health Vol 4,No 3,2009. Management of Ovarian Masses in Pregnancy. Trends in Gynaecology and Urology, Volume 14 Issue 1, p 14-17 (January/February 2009). Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure: A One Year Data Assessment. Kent and Sussex Journal of Obstetrics and Gynaecology. Vol. 6, issue 2, Jan 2008. Value of the MRI in the Preoperative Assessment of the Endometrial Cancer. Int. J. of O&G, Vol. 8 No.2, December 2007. Perioperative Factors Affecting the Hysteroscopic Hydrothermablation Procedure: A Six-month Assessment. Obstetrics & Gynaecology, News J. March 2006. Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Bleeding. East Sussex Journal of O&G. March, 2006. Unusual Presentation of Cervical Ectopic Pregnancy. East Sussex Journal of O&G, March 2006. Reproductive Health of Women: A review of the Panoramic Heritage. The Alex Journal of History of Medicine. Vol 30 -33, issue 1, April 2005. The use of low molecular weight heparin in pregnant woman with Mitral valve heart disease. Kuwait Medical Journal, March 2002, vol.39, No.5, 53-54. Mean 3rd Trimester Blood Sugar in Diabetic Kuwaiti Pregnant Females as a Predictor for Fetal Macrosomia. Medscape Women’s Health, (United States), Oct 2001, 6(5) p2. Chronic Pelvic Pain in Women. Obstetric and Gynaecology Survey. November issue 2001. Autologus Fascial Sling ,Does it really help the stress incontinence ,One year outcome data. Outcome of the Bulkamid periurethral injection.Outcome of the Vaginal suspension procedure for the years 19/20/21 Perioperative factors that affect the outcome of the pelvic floor surgery IUGA 2019 MRI ,CT scan versus TVS in the diagnosis and management of adnexal mass over 3 years (Oral presentation at the international gynaecology and gynae-oncology in China) 2013 Perioperative factors affecting the success of the HTA, a 3 years follow up at the 13th international world controversies in Ob.Gyn. and in, Berlin, Germany. 4-7/11/2010 Is there is a place for uterine conservation in the management of early stage endometrial cancer. RCOG international conference Abu-Dhabi Dec. 6,7,8th 2009. Value of TVS in the initial assessment of high-risk postmenopausal women. Annual RCOG international conference Abu-Dhabi Dec. 2009-09-13 (Poster) Is there is a place for the local hysteroscopic resection for malignant polypoidal endometrial cancer? Annual Southeast Gynaecology Tumour Group meeting. 17 September 2007. (oral) Value of the MRI, Hysteroscopy and TVS in the Preoperative Staging of Endometrial Cancer. 31st British International Congress of Obstetrics and Gynaecology 4-6 July/2007. (oral) Hysteroscopic Hydrothermablation: A novel Ablative Technique. Grand round oral presentation in the East Sussex NHS Trust monthly meeting. Evaluation of Perioperative Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure. Presented at the BSGE Annual Scientific meeting in Sheffield, May 2006. Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Women on Tamoxifen . Poster Presentation at the 19th EBCOG European Congress of Obstetrics and Gynaecology, April 2006, Torino, Italy. Induced Abortion Services in a District General Hospital. Poster presentation at the North Middlesex University Hospital Meeting, London, 26th May 2006. Outcome of the Hysteroscopy at Conquest Hospital over the last triennium 2004-2005. Part of the special skill module of the TVS in Gynaecology for the RCOG. Presented at the world 7th controversies in Obstetrics and Gynaecology in Athens, April 2005. Perinatal Mortality Audit at Jahra Hospital, Kuwait. Accepted by the CPD program of the RCOG 2001. Audit of the Outcome of the Burch Colposuspension over a 2-year period. Oral Presentation at the Annual Obstetrics and Gynaecology Conference, Kuwait Institute of Medical Specialisation, Kuwait 2003, Jahra Education & Training Master's Degree in Obstetrics and Gynaecology (Ain Shams University, Cairo, Egypt) FRCOG (Royal College of Obstetricians and Gynecologists) in the UK MD Doctorate Degree in Obstetrics and Gynecology (Ain Shams University, Cairo, Egypt) Royal College of Obstetrician and Gynecologist Subspecialty Modular training in Urogynaecology, minimally invasive laparoscopic and hysteroscopic surgery Membership British Society of Gynae-Endoscopy British Society of Urogynaecology

Biography Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy Breast cancer Solid tumor diagnosis Digestive cancer Gynecological cancer Lung cancer Genitourinary cancer Sarcoma Awards & Achievements Award from Himaya Foundations and University of Sharjah Research & Publications Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3. The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87. Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272. First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21